id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-E-4128-0005,FDA,FDA-2024-E-4128,Determination of Regulatory Review Period for Purposes of Patent Extension; ANKTIVA,Notice,Determinations,2026-09-09T04:00:00Z,2026,9,2026-09-09T04:00:00Z,2026-11-10T04:59:59Z,2026-09-09T17:49:59Z,2026-18297,1,0,09000064b94cc9f8
FDA-2024-E-4128-0004,FDA,FDA-2024-E-4128,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2025-11-07T05:00:00Z,2025,11,2025-11-07T05:00:00Z,,2025-11-08T00:00:10Z,,0,0,09000064b906daaf
FDA-2024-E-4128-0003,FDA,FDA-2024-E-4128,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2025-08-19T04:00:00Z,2025,8,2025-08-19T04:00:00Z,,2025-08-20T00:41:02Z,,0,0,09000064b8f07baf
FDA-2024-E-4128-0001,FDA,FDA-2024-E-4128,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-09-04T04:00:00Z,2024,9,2024-09-04T04:00:00Z,,2024-09-04T11:26:50Z,,0,0,09000064866b3d29
FDA-2024-E-4128-0002,FDA,FDA-2024-E-4128,"Patent Extension Application from Wilson Sonsini Goodrich and Rosati (on behalf of Altor BioScience, LLC)",Other,Application,2024-09-04T04:00:00Z,2024,9,2024-09-04T04:00:00Z,,2024-09-04T11:26:54Z,,0,0,09000064866b3d2a